Seeking Alpha
26 Sept 2026, 11:56 UTC · 2h ago
Verdict
Headline leans bullish. We score TMDX +0.80 across three claims.
Score confirms the headline.
Leans bullish
From its wording — no explicit rating
+0.80strongly bullish
What the story claims
3 claims · scored −1 bearish … +1 bullish · 0 new · 3 priced in
TransMedics targets revenue exceeding $2B by 2032.
Priced inanalysis piece discussing long-term growth drivers
So whatAchieving this target requires a significant CAGR over the next 6 years to scale from current levels.
More positive than 93% of claims this week
The kidney OCS product has a potential FDA submission date in 2027.
Continue reading
5 related stories
More positive than 88% of ticker scores this week
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
Priced inanalysis piece discussing upcoming product pipeline
So whatApproval would open a new addressable market beyond heart and lung transplants starting in late 2027 or 2028.
More positive than 79% of claims this week
Recent stock pullbacks were driven by margin volatility resulting from higher investments.
Priced inanalysis of recent price pullbacks
So whatIncreased CapEx for logistics networks will likely weigh on EPS in the immediate subsequent quarters.
More negative than 69% of claims this week
Which stocks this story touches
More positive than 88% of ticker scores this week
The company is described as a market-changing player with a 'buy' rating and significant long-term growth drivers.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Newsfile Corp
1h ago
—
TMDX hasn't traded since this ran. Last close $85.29 (Sep 25); the reaction starts at the next open.
TMDX chart →
